Continental Pellets Pharma Private Limited
About Continental Pellets Pharma Private Limited
Data last updated:
Continental Pellets Pharma Private Limited is a private limited company based in Hyderabad, Telangana, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 20 February 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Hyderabad, under CIN U85100TG2020PTC139385. Its GSTIN is 36AAICC6535H1ZJ (Telangana).
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors including Venkat Reddy Marakala and Savitri Tulluri.
Its last annual general meeting (AGM) was held on 25 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Hyderabad, Telangana.
As per the financials filed for FY 2025, the company reported a revenue of ₹15.98 Lakh, a decline of 64% compared to the previous year. For the same year it recorded a net profit of ₹13,382 (net margin 0.8%) and EBITDA of ₹13,382 (EBITDA margin 0.8%). Revenue has declined at a compounded annual rate (CAGR) of 21% over three years.
- EmailLocked
- TelephoneLocked
- WebsiteLocked
- Social MediaLocked
- Registered AddressPlot No 13 Block – B, Kavuri Hills G B Pet Madhapur, Hyderabad, Telangana, India – 500081
- IndustryPharma, Pharmaceutical Retailers & Distributors
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
Business Activity of Continental Pellets Pharma Private Limited
The main business activity of Continental Pellets Pharma is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Continental Pellets Pharma Private Limited FY 2025 filings available
Continental Pellets Pharma Private Limited reported revenue of ₹15.98 Lakh (down 64% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR) of Continental Pellets Pharma Private Limited
Revenue has declined at a compounded annual rate (CAGR) of 21% over three years, including a 64% fall in the latest year. EBITDA rose 255% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Continental Pellets Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹13,382 | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹13,382 | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Continental Pellets Pharma Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 0.8% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.8% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Continental Pellets Pharma are in the company report.
Financial statements from FY 2020
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Continental Pellets Pharma Private Limited
Continental Pellets Pharma has 3 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Venkat Reddy Marakala Also directs: Pelcygnus Formulations Private Limited | Director | 20 Feb 2020 | 6 Years 8 Months | Current |
| Savitri Tulluri Also directs: Pelcygnus Formulations Private Limited | Director | 20 Feb 2020 | 6 Years 8 Months | Current |
| Dushyanth Kalva Also directs: Pelcygnus Formulations Private Limited | Director | 08 Jan 2025 | 1 Years 9 Months | Current |
Peer Comparison of Continental Pellets Pharma Private Limited
Continental Pellets Pharma Private Limited is compared with the companies closest to it by revenue in the same principal business activity (Other Hospital and Medical Care Activities). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Triked Pharma Private Limited | ₹16.02 Lakh (FY 2022) | •••• | •••• | 161.0% | •••• | Kanpur, Uttar Pradesh, India |
| Good Healthcare Pathlabs Private Limited | ₹16.02 Lakh (FY 2024) | •••• | •••• | 47.0% | •••• | Bhopal, Madhya Pradesh, India |
| Digitalonco Solutions Private Limited | ₹16.01 Lakh (FY 2025) | •••• | •••• | -40.0% | •••• | Bangalore, Karnataka, India |
| KMD Biomedical Private Limited | ₹16 Lakh (FY 2022) | •••• | •••• | -23.0% | •••• | Ahmedabad, Gujarat, India |
| Good RX Mobility Private Limited | ₹16 Lakh (FY 2025) | •••• | •••• | 5210.0% | •••• | Vaikom, Kerala, India |
| Continental Pellets Pharma Private Limited this company | ₹15.98 Lakh (FY 2025) | •••• | •••• | -64.0% | •••• | Hyderabad, Telangana, India |
| MDC Global Welfare Foundation | ₹15.89 Lakh (FY 2024) | •••• | •••• | •••• | Chandigarh, India | |
| Plusandco Healthcare Services Private Limited | ₹15.88 Lakh (FY 2022) | •••• | •••• | 618.0% | •••• | Guwahati, Assam, India |
| Bhagwat Healthcare Foundation | ₹15.87 Lakh (FY 2024) | •••• | •••• | -10.0% | •••• | Latur, Maharashtra, India |
| Hi Tech Medical Industries Pvt Ltd | ₹15.87 Lakh (FY 2024) | •••• | •••• | -83.0% | •••• | Mumbai, Maharashtra, India |
| World Homeopathic Research Organization Private Limited | ₹15.87 Lakh (FY 2017) | •••• | •••• | 455.0% | •••• | Bhopal, Madhya Pradesh, India |
Peers are the five companies nearest above and the five nearest below Continental Pellets Pharma by revenue in the same principal business activity (Other Hospital and Medical Care Activities), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Continental Pellets Pharma Private Limited
Continental Pellets Pharma Private Limited is audited by SYB & Co for the financial year 2023.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| SYB & Co | Locked | Locked | Locked |
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Continental Pellets Pharma Private Limited
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Continental Pellets Pharma Private Limited
Continental Pellets Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.
Employees and EPFO Compliance at Continental Pellets Pharma Private Limited
Employment history and EPFO contributions of people linked to Continental Pellets Pharma.
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Continental Pellets Pharma Private Limited
Continental Pellets Pharma Private Limited has 7 board changes on record since 2020: 5 appointments and 2 cessations. The latest: Dushyanth Kalva was appointed as Director on 08 Jan 2025.
Credit Ratings, Litigation & Regulatory Alerts for Continental Pellets Pharma Private Limited
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Continental Pellets Pharma Private Limited
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Continental Pellets Pharma Private Limited
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Continental Pellets Pharma Private Limited
Continental Pellets Pharma has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 36AAICC6535H1ZJ | Telangana | Active | 09 Mar 2020 |
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Continental Pellets Pharma Private Limited
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Continental Pellets Pharma Private Limited
Continental Pellets Pharma is an active private limited company based in Hyderabad, Telangana, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 20 February 2020 (6+ years old) and is registered under CIN U85100TG2020PTC139385.
Continental Pellets Pharma reported revenue of ₹15.98 Lakh for FY 2025 (down 64% YoY).
Continental Pellets Pharma has 3 current directors:
- Venkat Reddy Marakala - Director
- Savitri Tulluri - Director
- Dushyanth Kalva - Director
Continental Pellets Pharma reported a net profit of ₹13,382 (net margin 0.8%) and EBITDA of ₹13,382 (EBITDA margin 0.8%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Continental Pellets Pharma is -21% over three years. In the latest year (FY 2025) revenue fell 64%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Continental Pellets Pharma is 36AAICC6535H1ZJ, registered in Telangana.
The CIN (Corporate Identification Number) of Continental Pellets Pharma is U85100TG2020PTC139385. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Continental Pellets Pharma was incorporated on 20 February 2020, making it 6+ years old. It is registered with the Registrar of Companies, Hyderabad.
The peers of Continental Pellets Pharma by revenue are Triked Pharma Private Limited, Good Healthcare Pathlabs Private Limited, Digitalonco Solutions Private Limited, KMD Biomedical Private Limited, Good RX Mobility Private Limited and 5 more, all in the same principal business activity (Other Hospital and Medical Care Activities).
Dushyanth Kalva was appointed as Director on 08 Jan 2025. Seelam Manojkumarreddy ceased to be Director on 28 Sep 2024. Vemireddy Srinivasa Reddy ceased to be Director on 20 Jun 2020. Continental Pellets Pharma has 7 board changes on record in total.
The registered office of Continental Pellets Pharma is at Plot No 13 Block – B, Kavuri Hills G B Pet Madhapur, Hyderabad, Telangana, India – 500081.